Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15603966rdf:typepubmed:Citationlld:pubmed
pubmed-article:15603966lifeskim:mentionsumls-concept:C0035236lld:lifeskim
pubmed-article:15603966lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:15603966lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:15603966lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:15603966lifeskim:mentionsumls-concept:C0034284lld:lifeskim
pubmed-article:15603966pubmed:issue2lld:pubmed
pubmed-article:15603966pubmed:dateCreated2004-12-17lld:pubmed
pubmed-article:15603966pubmed:abstractTextThe knowledge of SAR in a series of biphenyl anionic RSV inhibitors has been broadened by synthesis and testing of analogs with pyrimidine linkers. Generally, pyrimidine compounds were much harder to synthesize, and their anti-RSV activity was lower in comparison with triazine analogs.lld:pubmed
pubmed-article:15603966pubmed:languageenglld:pubmed
pubmed-article:15603966pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15603966pubmed:citationSubsetIMlld:pubmed
pubmed-article:15603966pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15603966pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15603966pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15603966pubmed:statusMEDLINElld:pubmed
pubmed-article:15603966pubmed:monthJanlld:pubmed
pubmed-article:15603966pubmed:issn0960-894Xlld:pubmed
pubmed-article:15603966pubmed:authorpubmed-author:RaifeldYuriYlld:pubmed
pubmed-article:15603966pubmed:authorpubmed-author:NewmanHowardHlld:pubmed
pubmed-article:15603966pubmed:authorpubmed-author:MitsnerBorisBlld:pubmed
pubmed-article:15603966pubmed:authorpubmed-author:NikitenkoAnto...lld:pubmed
pubmed-article:15603966pubmed:issnTypePrintlld:pubmed
pubmed-article:15603966pubmed:day17lld:pubmed
pubmed-article:15603966pubmed:volume15lld:pubmed
pubmed-article:15603966pubmed:ownerNLMlld:pubmed
pubmed-article:15603966pubmed:authorsCompleteYlld:pubmed
pubmed-article:15603966pubmed:pagination427-30lld:pubmed
pubmed-article:15603966pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:meshHeadingpubmed-meshheading:15603966...lld:pubmed
pubmed-article:15603966pubmed:year2005lld:pubmed
pubmed-article:15603966pubmed:articleTitlePyrimidine containing RSV fusion inhibitors.lld:pubmed
pubmed-article:15603966pubmed:affiliationChemical and Screening Sciences, Wyeth Research, 401 N. Middletown Rd, Pearl River, NY 10965, USA. nikitea@wyeth.comlld:pubmed
pubmed-article:15603966pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15603966pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15603966lld:chembl